BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation

N. Theodoropoulos, E. Wang, S. Penugonda, D. P. Ladner, V. Stosor, J. Leventhal, J. Friedewald, M. P. Angarone, M. G. Ison*

*Corresponding author for this work

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

BK virus nephropathy (BKVN) is a recognized cause of graft failure in kidney transplant recipients. There are limited data on the epidemiology of BK virus (BKV) infection after alemtuzumab induction. By clinical protocol, the kidney transplant recipients at our center were screened with BKV plasma PCR monthly for the first 4 months posttransplant then every 2-3 months for 2 years. A single center retrospective cohort study of all kidney transplant recipients from January 2008 to August 2010 was conducted to determine incidence and outcomes of BKV infection. Descriptive statistics and Kaplan-Meier analysis was performed. Of 666 recipients, 250 (37.5%) developed viruria, 80 (12%) developed viremia and 31 (4.7%) developed BKVN at a median of 17, 21 and 30 weeks, respectively. Induction with alemtuzumab did not significantly affect incidence of BKVN. Increased recipient age, African American race, acute graft rejection and CMV infection were significantly associated with the development of BKVN in multivariate analysis. The incidence of BK viruria, viremia and nephropathy was not significantly different among kidney transplant recipients who received alemtuzumab induction compared to patients receiving less potent induction. This retrospective cohort study of 666 kidney transplant recipients shows that the incidence of BK viruria, viremia and nephropathy is not significantly different among kidney transplant recipients who receive alemtuzumab induction when compared to patients who receive less potent induction. See article by Hirsch et al. on page 136.

Original languageEnglish (US)
Pages (from-to)197-206
Number of pages10
JournalAmerican Journal of Transplantation
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2013

Keywords

  • Alemtuzumab
  • BK virus nephropathy
  • kidney transplantation
  • lymphocyte depletion

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation'. Together they form a unique fingerprint.

  • Cite this